New data show that people with type 2 diabetes initiated on Forxiga®. (dapagliflozin) in UK real-world practice achieve results consistent with clinical trials

被引：0
|
作者：
Idris, Iskandar [1 ]
机构：
[1] Univ Nottingham, Nottingham NG7 2RD, England
来源：
DIABETES OBESITY & METABOLISM | 2015年 / 17卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1106 / 1106
页数：1
相关论文
共 50 条
  • [1] Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
    Lim, Lee-Ling
    Chow, Elaine
    Chan, Juliana C. N.
    NATURE REVIEWS ENDOCRINOLOGY, 2023, 19 (03) : 151 - 163
  • [2] Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
    Lee-Ling Lim
    Elaine Chow
    Juliana C. N. Chan
    Nature Reviews Endocrinology, 2023, 19 : 151 - 163
  • [3] Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
    Seo, Da Hea
    Suh, Young Ju
    Cho, Yongin
    Ahn, Seong Hee
    Seo, Seongha
    Hong, Seongbin
    Lee, Yong-Ho
    Choi, Young Ju
    Lee, Eunjig
    Kim, So Hun
    YONSEI MEDICAL JOURNAL, 2022, 63 (09) : 825 - 833
  • [4] The effect of insulin degludec in people with type 2 diabetes in real-world clinical practice in China
    Zhu, D.
    Chang, X.
    Lehrskov, L. L.
    Li, L.
    Nordentoft, M.
    Quan, J.
    Sha, Y.
    Xing, Z.
    Yang, C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [5] Generalisability of clinical trials of newer glucose-lowering drugs to real-world people with type 2 diabetes
    Butterly, E. W.
    Almazam, S. A.
    Alsallumi, K.
    McChrystal, R.
    Wei, L.
    McAllister, D. A.
    DIABETIC MEDICINE, 2023, 40
  • [6] A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe
    Fadini, Gian Paolo
    Tentolouris, Nikolaos
    Mateos, Irene Caballero
    Castaneda, Virginia Bellido
    Portillo, Cristobal Morales
    DIABETES THERAPY, 2020, 11 (02) : 423 - 436
  • [7] A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe
    Gian Paolo Fadini
    Nikolaos Tentolouris
    Irene Caballero Mateos
    Virginia Bellido Castañeda
    Cristóbal Morales Portillo
    Diabetes Therapy, 2020, 11 : 423 - 436
  • [8] Heart failure among people with Type 2 diabetes mellitus: real-world data of 289 954 people from a diabetes database
    Stoyanova, D.
    Stratmann, B.
    Schwandt, A.
    Heise, N.
    Muehldorfer, S.
    Ziegelasch, H-J
    Zimmermann, A.
    Tschoepe, D.
    Holl, R. W.
    DIABETIC MEDICINE, 2020, 37 (08) : 1291 - 1298
  • [9] Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
    McGovern, Andrew
    Hinton, William
    Correa, Ana
    Munro, Neil
    Whyte, Martin
    de Lusignan, Simon
    BMJ OPEN, 2016, 6 (11):
  • [10] Clinical results of randomized trials and "real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research
    Zambonin, Valentina
    De Toma, Alessandro
    Carbognin, Luisa
    Nortilli, Rolando
    Fiorio, Elena
    Parolin, Veronica
    Pilotto, Sara
    Cuppone, Federica
    Pellini, Francesca
    Lombardi, Davide
    Pollini, Giovanni Paolo
    Tortora, Giampaolo
    Bria, Emilio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (04) : 497 - 506
12345